Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

Stefano Monti, Kerry J. Savage, Jeffery L. Kutok, Friedrich Feuerhake, Paul Kurtin, Martin Mihm, Bingyan Wu, Laura Pasqualucci, Donna Neuberg, Ricardo C T Aguiar, Paola Dal Cin, Christine Marie Ladd-Acosta, Geraldine S. Pinkus, Gilles Salles, Nancy Lee Harris, Riccardo Dalla-Favera, Thomas M. Habermann, Jon C. Aster, Todd R. Golub, Margaret A. Shipp

Research output: Contribution to journalArticle

Abstract

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with recognized variability in clinical outcome, genetic features, and cells of origin. To date, transcriptional profiling has been used to highlight similarities between DLBCL tumor cells and normal B-cell subtypes and associate genes and pathways with unfavorable outcome. To identify robust and highly reproducible DLBCL subtypes with comprehensive transcriptional signatures, we used a large series of newly diagnosed DLBCLs, whole genome arrays, and multiple clustering methods. Tumors were also analyzed for known common genetic abnormalities in DLBCL. There were 3 discrete subsets of DLBCL - "oxidative phosphorylation," "B-cell receptor/proliferation," and "host response" (HR) - identified characterized using gene set enrichment analysis and confirmed in an independent series. HR tumors had increased expression of T/natural killer cell receptor and activation pathway components, complement cascade members, macrophage/dendritic cell markers, and inflammatory mediators. HR DLB-CLs also contained significantly higher numbers of morphologically distinct CD2 +/CD3 + tumor-infiltrating lymphocytes and interdigitating S100 +/gamma interferon-induced lysosomal transferase-positive (GILT +) CD1a -/CD123 - dendritic cells. The HR cluster shared features of histologically defined T-cell/histiocyte-rich B-cell lymphoma, including fewer genetic abnormalities, younger age at presentation, and frequent splenic and bone marrow involvement. These studies identify tumor microenvironment and host inflammatory response as defining features in DLBCL and suggest rational treatment targets in specific DLBCL subsets.

Original languageEnglish (US)
Pages (from-to)1851-1861
Number of pages11
JournalBlood
Volume105
Issue number5
DOIs
StatePublished - Mar 1 2005
Externally publishedYes

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Tumors
Cells
Genes
Dendritic Cells
Natural Killer Cell Receptors
B-Lymphocytes
T-cells
Lymphocytes
Macrophages
B-Lymphocyte Subsets
Tumor-Infiltrating Lymphocytes
Neoplasms
Transferases
Histiocytes
Tumor Microenvironment
Oxidative Phosphorylation
Interferon-gamma
B-Cell Lymphoma
Bone

ASJC Scopus subject areas

  • Hematology

Cite this

Monti, S., Savage, K. J., Kutok, J. L., Feuerhake, F., Kurtin, P., Mihm, M., ... Shipp, M. A. (2005). Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood, 105(5), 1851-1861. https://doi.org/10.1182/blood-2004-07-2947

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. / Monti, Stefano; Savage, Kerry J.; Kutok, Jeffery L.; Feuerhake, Friedrich; Kurtin, Paul; Mihm, Martin; Wu, Bingyan; Pasqualucci, Laura; Neuberg, Donna; Aguiar, Ricardo C T; Cin, Paola Dal; Ladd-Acosta, Christine Marie; Pinkus, Geraldine S.; Salles, Gilles; Harris, Nancy Lee; Dalla-Favera, Riccardo; Habermann, Thomas M.; Aster, Jon C.; Golub, Todd R.; Shipp, Margaret A.

In: Blood, Vol. 105, No. 5, 01.03.2005, p. 1851-1861.

Research output: Contribution to journalArticle

Monti, S, Savage, KJ, Kutok, JL, Feuerhake, F, Kurtin, P, Mihm, M, Wu, B, Pasqualucci, L, Neuberg, D, Aguiar, RCT, Cin, PD, Ladd-Acosta, CM, Pinkus, GS, Salles, G, Harris, NL, Dalla-Favera, R, Habermann, TM, Aster, JC, Golub, TR & Shipp, MA 2005, 'Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response', Blood, vol. 105, no. 5, pp. 1851-1861. https://doi.org/10.1182/blood-2004-07-2947
Monti, Stefano ; Savage, Kerry J. ; Kutok, Jeffery L. ; Feuerhake, Friedrich ; Kurtin, Paul ; Mihm, Martin ; Wu, Bingyan ; Pasqualucci, Laura ; Neuberg, Donna ; Aguiar, Ricardo C T ; Cin, Paola Dal ; Ladd-Acosta, Christine Marie ; Pinkus, Geraldine S. ; Salles, Gilles ; Harris, Nancy Lee ; Dalla-Favera, Riccardo ; Habermann, Thomas M. ; Aster, Jon C. ; Golub, Todd R. ; Shipp, Margaret A. / Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. In: Blood. 2005 ; Vol. 105, No. 5. pp. 1851-1861.
@article{7bed2df552464c4a9eb6d8e42aa47b22,
title = "Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response",
abstract = "Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with recognized variability in clinical outcome, genetic features, and cells of origin. To date, transcriptional profiling has been used to highlight similarities between DLBCL tumor cells and normal B-cell subtypes and associate genes and pathways with unfavorable outcome. To identify robust and highly reproducible DLBCL subtypes with comprehensive transcriptional signatures, we used a large series of newly diagnosed DLBCLs, whole genome arrays, and multiple clustering methods. Tumors were also analyzed for known common genetic abnormalities in DLBCL. There were 3 discrete subsets of DLBCL - {"}oxidative phosphorylation,{"} {"}B-cell receptor/proliferation,{"} and {"}host response{"} (HR) - identified characterized using gene set enrichment analysis and confirmed in an independent series. HR tumors had increased expression of T/natural killer cell receptor and activation pathway components, complement cascade members, macrophage/dendritic cell markers, and inflammatory mediators. HR DLB-CLs also contained significantly higher numbers of morphologically distinct CD2 +/CD3 + tumor-infiltrating lymphocytes and interdigitating S100 +/gamma interferon-induced lysosomal transferase-positive (GILT +) CD1a -/CD123 - dendritic cells. The HR cluster shared features of histologically defined T-cell/histiocyte-rich B-cell lymphoma, including fewer genetic abnormalities, younger age at presentation, and frequent splenic and bone marrow involvement. These studies identify tumor microenvironment and host inflammatory response as defining features in DLBCL and suggest rational treatment targets in specific DLBCL subsets.",
author = "Stefano Monti and Savage, {Kerry J.} and Kutok, {Jeffery L.} and Friedrich Feuerhake and Paul Kurtin and Martin Mihm and Bingyan Wu and Laura Pasqualucci and Donna Neuberg and Aguiar, {Ricardo C T} and Cin, {Paola Dal} and Ladd-Acosta, {Christine Marie} and Pinkus, {Geraldine S.} and Gilles Salles and Harris, {Nancy Lee} and Riccardo Dalla-Favera and Habermann, {Thomas M.} and Aster, {Jon C.} and Golub, {Todd R.} and Shipp, {Margaret A.}",
year = "2005",
month = "3",
day = "1",
doi = "10.1182/blood-2004-07-2947",
language = "English (US)",
volume = "105",
pages = "1851--1861",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "5",

}

TY - JOUR

T1 - Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

AU - Monti, Stefano

AU - Savage, Kerry J.

AU - Kutok, Jeffery L.

AU - Feuerhake, Friedrich

AU - Kurtin, Paul

AU - Mihm, Martin

AU - Wu, Bingyan

AU - Pasqualucci, Laura

AU - Neuberg, Donna

AU - Aguiar, Ricardo C T

AU - Cin, Paola Dal

AU - Ladd-Acosta, Christine Marie

AU - Pinkus, Geraldine S.

AU - Salles, Gilles

AU - Harris, Nancy Lee

AU - Dalla-Favera, Riccardo

AU - Habermann, Thomas M.

AU - Aster, Jon C.

AU - Golub, Todd R.

AU - Shipp, Margaret A.

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with recognized variability in clinical outcome, genetic features, and cells of origin. To date, transcriptional profiling has been used to highlight similarities between DLBCL tumor cells and normal B-cell subtypes and associate genes and pathways with unfavorable outcome. To identify robust and highly reproducible DLBCL subtypes with comprehensive transcriptional signatures, we used a large series of newly diagnosed DLBCLs, whole genome arrays, and multiple clustering methods. Tumors were also analyzed for known common genetic abnormalities in DLBCL. There were 3 discrete subsets of DLBCL - "oxidative phosphorylation," "B-cell receptor/proliferation," and "host response" (HR) - identified characterized using gene set enrichment analysis and confirmed in an independent series. HR tumors had increased expression of T/natural killer cell receptor and activation pathway components, complement cascade members, macrophage/dendritic cell markers, and inflammatory mediators. HR DLB-CLs also contained significantly higher numbers of morphologically distinct CD2 +/CD3 + tumor-infiltrating lymphocytes and interdigitating S100 +/gamma interferon-induced lysosomal transferase-positive (GILT +) CD1a -/CD123 - dendritic cells. The HR cluster shared features of histologically defined T-cell/histiocyte-rich B-cell lymphoma, including fewer genetic abnormalities, younger age at presentation, and frequent splenic and bone marrow involvement. These studies identify tumor microenvironment and host inflammatory response as defining features in DLBCL and suggest rational treatment targets in specific DLBCL subsets.

AB - Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with recognized variability in clinical outcome, genetic features, and cells of origin. To date, transcriptional profiling has been used to highlight similarities between DLBCL tumor cells and normal B-cell subtypes and associate genes and pathways with unfavorable outcome. To identify robust and highly reproducible DLBCL subtypes with comprehensive transcriptional signatures, we used a large series of newly diagnosed DLBCLs, whole genome arrays, and multiple clustering methods. Tumors were also analyzed for known common genetic abnormalities in DLBCL. There were 3 discrete subsets of DLBCL - "oxidative phosphorylation," "B-cell receptor/proliferation," and "host response" (HR) - identified characterized using gene set enrichment analysis and confirmed in an independent series. HR tumors had increased expression of T/natural killer cell receptor and activation pathway components, complement cascade members, macrophage/dendritic cell markers, and inflammatory mediators. HR DLB-CLs also contained significantly higher numbers of morphologically distinct CD2 +/CD3 + tumor-infiltrating lymphocytes and interdigitating S100 +/gamma interferon-induced lysosomal transferase-positive (GILT +) CD1a -/CD123 - dendritic cells. The HR cluster shared features of histologically defined T-cell/histiocyte-rich B-cell lymphoma, including fewer genetic abnormalities, younger age at presentation, and frequent splenic and bone marrow involvement. These studies identify tumor microenvironment and host inflammatory response as defining features in DLBCL and suggest rational treatment targets in specific DLBCL subsets.

UR - http://www.scopus.com/inward/record.url?scp=20144382754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144382754&partnerID=8YFLogxK

U2 - 10.1182/blood-2004-07-2947

DO - 10.1182/blood-2004-07-2947

M3 - Article

C2 - 15550490

AN - SCOPUS:20144382754

VL - 105

SP - 1851

EP - 1861

JO - Blood

JF - Blood

SN - 0006-4971

IS - 5

ER -